176 related articles for article (PubMed ID: 10521585)
1. Acute injection of drugs with low addictive potential (delta(9)-tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting drugs (cocaine and morphine).
Erdtmann-Vourliotis M; Mayer P; Riechert U; Höllt V
Brain Res Mol Brain Res; 1999 Aug; 71(2):313-24. PubMed ID: 10521585
[TBL] [Abstract][Full Text] [Related]
2. Prior experience of morphine application alters the c-fos response to MDMA ('ecstasy') and cocaine in the rat striatum.
Erdtmann-Vourliotis M; Mayer P; Riechert U; Höllt V
Brain Res Mol Brain Res; 2000 Apr; 77(1):55-64. PubMed ID: 10814832
[TBL] [Abstract][Full Text] [Related]
3. Distinct patterns of DeltaFosB induction in brain by drugs of abuse.
Perrotti LI; Weaver RR; Robison B; Renthal W; Maze I; Yazdani S; Elmore RG; Knapp DJ; Selley DE; Martin BR; Sim-Selley L; Bachtell RK; Self DW; Nestler EJ
Synapse; 2008 May; 62(5):358-69. PubMed ID: 18293355
[TBL] [Abstract][Full Text] [Related]
4. Long-lasting sensitization towards morphine in motoric and limbic areas as determined by c-fos expression in rat brain.
Erdtmann-Vourliotis M; Mayer P; Linke R; Riechert U; Höllt V
Brain Res Mol Brain Res; 1999 Sep; 72(1):1-16. PubMed ID: 10521594
[TBL] [Abstract][Full Text] [Related]
5. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors.
Gresch PJ; Strickland LV; Sanders-Bush E
Neuroscience; 2002; 114(3):707-13. PubMed ID: 12220572
[TBL] [Abstract][Full Text] [Related]
6. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
Singh ME; McGregor IS; Mallet PE
Neuropharmacology; 2005 Dec; 49(8):1189-200. PubMed ID: 16137723
[TBL] [Abstract][Full Text] [Related]
7. High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")-induced Fos expression in a region-specific manner.
Hargreaves GA; Hunt GE; Cornish JL; McGregor IS
Neuroscience; 2007 Mar; 145(2):764-74. PubMed ID: 17289273
[TBL] [Abstract][Full Text] [Related]
8. The involvement of accumbal glycine receptors in the dopamine-elevating effects of addictive drugs.
Jonsson S; Adermark L; Ericson M; Söderpalm B
Neuropharmacology; 2014 Jul; 82():69-75. PubMed ID: 24686030
[TBL] [Abstract][Full Text] [Related]
9. Sexual dimorphism in the response to N-methyl-D-aspartate receptor antagonists and morphine on behavior and c-Fos induction in the rat brain.
D'Souza DN; Harlan RE; Garcia MM
Neuroscience; 1999; 93(4):1539-47. PubMed ID: 10501478
[TBL] [Abstract][Full Text] [Related]
10. Identification of brain regions that are markedly activated by morphine in tolerant but not in naive rats.
Erdtmann-Vourliotis M; Mayer P; Riechert U; Grecksch G; Höllt V
Brain Res Mol Brain Res; 1998 Oct; 61(1-2):51-61. PubMed ID: 9795131
[TBL] [Abstract][Full Text] [Related]
11. The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain.
Stephenson CP; Hunt GE; Topple AN; McGregor IS
Neuroscience; 1999; 92(3):1011-23. PubMed ID: 10426541
[TBL] [Abstract][Full Text] [Related]
12. Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression.
Colussi-Mas J; Schenk S
Eur J Neurosci; 2008 Nov; 28(9):1895-910. PubMed ID: 18973603
[TBL] [Abstract][Full Text] [Related]
13. Morphine- and cocaine-induced c-Fos levels in Lewis and Fischer rat strains.
Grabus SD; Glowa JR; Riley AL
Brain Res; 2004 Feb; 998(1):20-8. PubMed ID: 14725964
[TBL] [Abstract][Full Text] [Related]
14. Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity.
Singh ME; McGregor IS; Mallet PE
Neuropsychopharmacology; 2006 Jan; 31(1):58-69. PubMed ID: 15920503
[TBL] [Abstract][Full Text] [Related]
15. Spatiotemporal analysis of Fos expression associated with cocaine- and PTZ-induced seizures in prenatally cocaine-treated rats.
Snyder-Keller A; Keller RW
Exp Neurol; 2001 Jul; 170(1):109-20. PubMed ID: 11421588
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
Baker LE; Taylor MM
Pharmacol Biochem Behav; 1997 Aug; 57(4):737-48. PubMed ID: 9259001
[TBL] [Abstract][Full Text] [Related]
17. Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain.
Valjent E; Pagès C; Hervé D; Girault JA; Caboche J
Eur J Neurosci; 2004 Apr; 19(7):1826-36. PubMed ID: 15078556
[TBL] [Abstract][Full Text] [Related]
18. 'Candyflipping': synergistic discriminative effect of LSD and MDMA.
Schechter MD
Eur J Pharmacol; 1998 Jan; 341(2-3):131-4. PubMed ID: 9543229
[TBL] [Abstract][Full Text] [Related]
19. NMDA and D1 receptors mediate induction of c-fos and junB genes in striatum following morphine administration: implications for studies of memory.
Sharp FR; Liu J; Nickolenko J; Bontempi B
Behav Brain Res; 1995 Jan; 66(1-2):225-30. PubMed ID: 7755894
[TBL] [Abstract][Full Text] [Related]
20. 3,4-Methylenedioxymetamphetamine (ecstasy) induces c-fos-like protein and mRNA in rat organotypic dorsal striatal slices.
Schatz DS; Kaufmann WA; Schuligoi R; Humpel C; Saria A
Synapse; 2000 Apr; 36(1):75-83. PubMed ID: 10700028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
